Related Experiment Video
Updated: Jun 15, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside
Chau-Ching Liu1, Susan Manzi, Amy H Kao
1Lupus Center of Excellence, University of Pittsburgh School of Health Sciences, Pittsburgh, PA 15260, USA.
Rheumatic Diseases Clinics of North America
|March 6, 2010
Summary
Systemic lupus erythematosus (SLE) is a diverse autoimmune disease. This article reviews key biomarkers aiding in SLE diagnosis, incorporating original research findings.
Area of Science:
- Immunology
- Rheumatology
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) presents significant diagnostic challenges due to its heterogeneous clinical and serological manifestations.
- Accurate diagnosis is crucial for timely and effective patient management.
Purpose of the Study:
- To identify and highlight key biomarkers that are valuable for the diagnosis of systemic lupus erythematosus.
- To present novel research findings related to SLE biomarkers.
Main Methods:
- Comprehensive review of existing literature on SLE diagnostic biomarkers.
- Presentation and analysis of the authors' original research data on specific biomarkers.
Main Results:
- Discussion of established and emerging biomarkers for SLE diagnosis.
- Presentation of new data supporting the utility of certain biomarkers in SLE detection.
Conclusions:
- Biomarkers play a critical role in the accurate diagnosis of systemic lupus erythematosus.
- Continued research into novel biomarkers will further refine SLE diagnostic strategies.
